Background: Platelet-rich plasma (PRP) injections have recently been marketed as a form of autologous cell therapy under the banner of regenerative medicine despite limited scientific evidence on its use for treating erectile dysfunction (ED).
Aim: To evaluate the evidence on PRP treatment for ED and determine the current trends in provision of this treatment.
Methods: A critical review of the literature on PRP using the PubMed and Embase databases.
Outcomes: This narrative review focuses on the clinical use of, regulation of, and evidence for PRP in the treatment of ED.
Results: There is a limited number of published peer-reviewed articles demonstrating clinical outcomes pertaining to the use of PRP for ED in human. The technique of PRP application for ED is currently patented, with a global total of 683 registered clinics. The majority of PRP clinics do not provide cost estimates on their websites.
Conclusion: Despite a global presence of PRP clinics and ongoing active marketing and public interest in regenerative medicine, no scientific evidence has been published to establish an evidence-based risk-benefit profile for PRP use for ED in humans. Given the limited data on clinical efficacy and potential harmful side effects, there is a need for a proper clinical trial to examine the role of PRP before it is accepted as standard of care in treatment for ED. Scott S, Roberts M, Chung E. Platelet-Rich Plasma and Treatment of Erectile Dysfunction: Critical Review of Literature and Global Trends in Platelet-Rich Plasma Clinics. Sex Med Rev 2019;7:306-312.
Keywords: Autologous blood; Erectile dysfunction; Growth factors; Platelet-rich plasma.
Copyright © 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.